Outcomes of percutaneous coronary interventions performed at centers without and with onsite coronary artery bypass graft surgery

被引:86
作者
Wennberg, DE
Lucas, FL
Siewers, AE
Kellett, MA
Malenka, DJ
机构
[1] Ctr Outcomes Res & Evaluat, Portland, ME 04101 USA
[2] Maine Med Ctr, Dept Med, Portland, ME 04102 USA
[3] Dartmouth Coll, Hitchcock Med Ctr, Dartmouth Med Sch, Ctr Evaluat Clin Sci, Hanover, NH 03756 USA
[4] Dartmouth Hitchcock Med Ctr, Dept Cardiol, Lebanon, NH 03766 USA
来源
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 2004年 / 292卷 / 16期
关键词
D O I
10.1001/jama.292.16.1961
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Context An ongoing debate focuses on whether institutions should perform percutaneous coronary interventions (PCIs) without an onsite coronary artery bypass graft (CABG) surgery program. Objective To compare patient outcomes following PCI at US institutions performing this procedure without and with onsite cardiac surgery. Design, Setting, and Patients Medicare hospital (part A) data were used to identify PCIs performed on fee-for-service Medicare enrollees (n=625854) aged at least 65 years at acute care facilities between January 1, 1999, and December 1, 2001. Hospitals without and with onsite cardiac surgery were identified based on the presence of claims for CABG surgery. Patients were characterized as undergoing primary/rescue PCI, defined as an emergency procedure performed on the same day of admission for an acute myocardial infarction (MI), vs all other PCIs. Main Outcome Measures Post-PCI CABG surgery and combined in-hospital and 30-day mortality. Results A total of 178 hospitals performed PCIs without onsite cardiac surgery and 943 hospitals performed PCIs with onsite cardiac surgery. Patients undergoing PCIs in hospitals without onsite cardiac surgery were similar to those with onsite cardiac surgery with respect to age, sex, race, and measurable comorbidities; however, patients undergoing PCIs in hospitals without onsite cardiac surgery were more likely to have a primary/rescue PCI (22.0% vs 5.6%, P<.001). Patients undergoing PCIs in hospitals without cardiac surgery were more likely to die (6.0% vs 3.3%; adjusted odds ratio [OR], 1.29; 95% confidence interval [CI], 1.14-1.47; P<.001). After accounting for baseline differences, mortality for patients with primary/rescue PCI was similar in institutions without and with cardiac surgery (adjusted OR, 0.93; 95% Cl, 0.80-1.08; P=34). However, for the larger non-primary/rescue PCI population, mortality was higher in hospitals without onsite cardiac surgery (adjusted OR, 1.38; 95% Cl, 1.14-1.67; P=.001). This increase in mortality was primarily confined to hospitals performing 50 or less Medicare PCIs per year. Conclusions Percutaneous coronary interventions in hospitals without onsite cardiac surgery are often performed for reasons other than immediate treatment of an MI and are associated with a higher risk of adverse outcomes. Policies aimed at increasing access to primary/rescue PCI through promoting PCI in hospitals without cardiac surgery may inadvertently lead to an overall increase in mortality related to PCI.
引用
收藏
页码:1961 / 1968
页数:8
相关论文
共 42 条
  • [1] *AM HEART ASS, 2002, HEART DIS STROK STAT
  • [2] A comparison of coronary angioplasty with fibrinolytic therapy in acute myocardial infarction
    Andersen, HR
    Nielsen, TT
    Rasmussen, K
    Thuesen, L
    Kelbaek, H
    Thayssen, P
    Abildgaard, U
    Pedersen, F
    Madsen, JK
    Grande, P
    Villadsen, AB
    Krusell, LR
    Haghfelt, T
    Lomholt, P
    Husted, SE
    Vigholt, E
    Kjaergard, HK
    Mortensen, LS
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2003, 349 (08) : 733 - 742
  • [3] [Anonymous], 1999, INT CLASS DIS
  • [4] Thrombolytic therapy vs primary percutaneous coronary intervention for myocardial infarction in patients presenting to hospitals without on-site cardiac surgery - A randomized controlled trial
    Aversano, T
    Aversano, LT
    Passamani, E
    Knatterud, GL
    Terrin, ML
    Williams, DO
    Forman, SA
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 287 (15): : 1943 - 1951
  • [5] Brush JE, 1996, J INVASIVE CARDIOL, V8, P91
  • [6] USE OF A MONOCLONAL-ANTIBODY DIRECTED AGAINST THE PLATELET GLYCOPROTEIN IIB/IIIA RECEPTOR IN HIGH-RISK CORONARY ANGIOPLASTY
    CALIFF, RM
    SHADOFF, N
    VALETT, N
    BATES, E
    GALEANA, A
    KNOPF, W
    SHAFTEL, J
    BENDER, MJ
    AVERSANO, T
    RAQUENO, J
    GURBEL, P
    COWFER, J
    COHEN, M
    CROSS, P
    BITTL, J
    EDDINGS, K
    TAYLOR, M
    DEROSA, K
    HATTEL, L
    COOPER, L
    ESHELMAN, B
    FINTEL, D
    NIEMYSKI, P
    KLEIN, L
    KENNEDY, H
    THORNTON, T
    KEREIAKES, D
    MARTIN, L
    ANDERSON, L
    HIGBY, N
    ELLIS, S
    BREZINA, K
    GEORGE, B
    CHAPEKIS, A
    SMITH, D
    ANWAR, A
    GERBER, TL
    PRITCHARD, GL
    MYLER, R
    SHAW, R
    MURPHY, M
    WARD, K
    MADIGAN, NP
    BLANKENSHIP, J
    HALBERT, M
    FLANAGAN, C
    TANNENBAUM, M
    POLICH, M
    STEVENSON, C
    TCHENG, J
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1994, 330 (14) : 956 - 961
  • [7] Primary percutaneous coronary intervention for all?
    Cannon, CP
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 287 (15): : 1987 - 1989
  • [8] DELLAVALLE A, 1995, CORONARY ARTERY DIS, V6, P513
  • [9] A RANDOMIZED COMPARISON OF CORONARY-STENT PLACEMENT AND BALLOON ANGIOPLASTY IN THE TREATMENT OF CORONARY-ARTERY DISEASE
    FISCHMAN, DL
    LEON, MB
    BAIM, DS
    SCHATZ, RA
    SAVAGE, MP
    PENN, I
    DETRE, K
    VELTRI, L
    RICCI, D
    NOBUYOSHI, M
    CLEMAN, M
    HEUSER, R
    ALMOND, D
    TEIRSTEIN, PS
    FISH, RD
    COLOMBO, A
    BRINKER, J
    MOSES, J
    SHAKNOVICH, A
    HIRSHFELD, J
    BAILEY, S
    ELLIS, S
    RAKE, R
    GOLDBERG, S
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1994, 331 (08) : 496 - 501
  • [10] Health care quality, geographic variations, and the challenge of supply-sensitive care
    Fisher, ES
    Wennberg, JE
    [J]. PERSPECTIVES IN BIOLOGY AND MEDICINE, 2003, 46 (01) : 69 - 79